Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[EEG changes during sedation with gamma-hydroxybutyric acid]

E Entholzner1, L Mielke, R Pichlmeier

  • 1Institut für Anaesthesiologie, Technischen Universität München.

Der Anaesthesist
|May 1, 1995
PubMed
Summary

Gamma-hydroxybutyric acid (GHB) effectively sedates patients without causing seizure-like activity, contrary to animal studies. Clinical use in humans shows it is safe and potentially requires lower doses than previously thought.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lenvatinib as salvage therapy in advanced and progressive GI-NET.

Endocrine-related cancer·2025
Same author

Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection.

European journal of pediatrics·2024
Same author

Usability and preliminary effectiveness of an app-based physical activity and education program for people with hip or knee osteoarthritis - a pilot randomized controlled trial.

Arthritis research & therapy·2024
Same author

Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz™).

Pathology, research and practice·2023
Same author

[Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Chirurgie (Heidelberg, Germany)·2022
Same author

[Reddish painless rapidly growing tumor of the upper eyelid with a smooth surface: Merkel cell carcinoma].

Die Ophthalmologie·2022

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Pharmacology

Background:

  • Gamma-hydroxybutyric acid (GHB) is a neurotransmitter with anesthetic and sedative properties.
  • While effective, its unpredictable duration and potential for seizure-like activity in animals raise concerns.
  • GHB is used in intensive care units (ICUs) for sedation, particularly in mechanically ventilated patients.

Purpose of the Study:

  • To evaluate the electroencephalographic (EEG) effects of GHB sedation in patients undergoing major abdominal surgery.
  • To determine if GHB induces seizure-like activity in humans at clinical doses.
  • To assess the safety and efficacy of GHB for sedation in a clinical setting.

Main Methods:

  • 31 patients received GHB (50 mg/kg BW) intravenously for sedation post-abdominal surgery.

Related Experiment Videos

  • Continuous multichannel EEG monitoring with spectral analysis and brain mapping was performed.
  • EEG data was analyzed both automatically and visually by a neurologist to detect seizure activity.

    • Main Results:

    • GHB administration resulted in EEG patterns shifting to slow delta-theta or delta rhythms.
    • Alpha and beta activity decreased, while delta activity increased, predominantly in frontal and central areas.
    • No seizure-like electrical activity was observed in any patient, despite some exhibiting burst-suppression patterns.

    Conclusions:

    • Animal study findings regarding seizure-like activity with GHB do not appear to translate to human use at clinically relevant doses.
    • GHB is a safe sedative agent for humans, even at doses higher than those used in this study.
    • The observed EEG changes suggest that effective sedation may be achieved with doses lower than 50 mg/kg BW.